Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
5,64 USD | +3,49% | -5,84% | -62,12% |
Attività
Numero di dipendenti: 74
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jaume Pons
FOU | Founder | 58 | 01/04/15 |
Jason Lettmann
CEO | Chief Executive Officer | 46 | 01/04/20 |
Peter García
DFI | Director of Finance/CFO | 62 | 01/01/20 |
Chief Tech/Sci/R&D Officer | - | 01/11/21 | |
Sophia Randolph
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/06/16 |
Michael Chang
COO | Chief Operating Officer | - | 01/03/15 |
Shelly Pinto
AUD | Comptroller/Controller/Auditor | 48 | 03/05/21 |
Hong I. Wan
PRN | Corporate Officer/Principal | - | 01/04/15 |
Hank Stern
PRN | Corporate Officer/Principal | - | 01/01/15 |
Chris Byrd
LAW | General Counsel | - | 01/05/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 28/11/22 |
Corey Goodman
CHM | Chairman | 72 | 01/03/15 |
Jason Lettmann
CEO | Chief Executive Officer | 46 | 01/04/20 |
Rekha Hemrajani
BRD | Director/Board Member | 54 | 01/04/20 |
Jaume Pons
FOU | Founder | 58 | 01/04/15 |
Sophia Randolph
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/06/16 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 52 100 107 | 41 331 399 ( 79,33 %) | 0 | 79,33 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-62,12% | 284 Mln | |
+18,43% | 122 Mrd | |
+19,81% | 112 Mrd | |
-23,74% | 19,33 Mrd | |
-18,45% | 16,17 Mrd | |
-19,97% | 15,6 Mrd | |
-49,33% | 14,65 Mrd | |
+57,08% | 14,34 Mrd | |
+7,95% | 14 Mrd | |
+126,04% | 11,29 Mrd |
- Borsa valori
- Azioni
- Azione ALXO
- Società ALX Oncology Holdings Inc.